Wellgistics Health (WGRX) Board of Directors has approved an $8.1M debt-to-equity conversion. Led by CEO Brian Norton and former minority partners of Wellgistics, which was acquired by Wellgistics Health in 2024, the transaction strengthens the Company’s balance sheet by materially reducing the Company’s short-term debt. The transaction is also expected to: Accelerate the Company’s cash flow by unlocking more favorable terms and capital access; Improve Wellgistics Health’s ability to acquire high-demand pharmaceutical products at competitive prices; Expand the Company’s national footprint by growing its network of independent pharmacies; and Strengthen the Company’s proprietary technology platform, including AI-powered hub services and digital prescription routing
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGRX:
- Wellgistics Health files to sell common stock, warrants, no amount given
- Wellgistics Health accelerates platform growth in Q2
- Wellgistics Health announces membership in OptiSource
- Wellgistics Health announces preliminary inclusion in Russell 2000, 3000 Indexes
- Wellgistics Health appoints Tony Madsen as COO, Shelley Bailey as CRO